Knowledge (XXG)

Template:Antipsoriatics

Source 📝

37: 149: 243: 286: 370: 30: 260: 365: 248: 290: 254: 359: 300: 46: 144: 133: 50: 15: 197: 192: 117: 220: 165: 159: 154: 112: 86: 225: 202: 139: 94: 212: 104: 76: 328:
will show the template collapsed, i.e. hidden apart from its title bar.
293:), it is hidden apart from its title bar; if not, it is fully visible. 285:, meaning that if there is another collapsible item on the page (a 19: 72: 352:
will show the template expanded, i.e. fully visible.
331: 307: 211: 185: 178: 126: 103: 85: 65: 58: 296:To change this template's initial visibility, the 31: 8: 182: 62: 38: 24: 16: 280:initial visibility currently defaults to 297: 7: 291:table with the collapsible attribute 14: 1: 387: 150:Calcipotriol/betamethasone 238: 47:Drugs used for psoriasis 371:Drug templates by ATC 265:Never to phase III 275: 274: 234: 233: 174: 173: 378: 351: 350: 346: 343: 340: 337: 334: 327: 326: 322: 319: 316: 313: 310: 299: 298:|state= 283: 278:This template's 183: 63: 40: 33: 26: 17: 386: 385: 381: 380: 379: 377: 376: 375: 356: 355: 348: 344: 341: 338: 335: 332: 324: 320: 317: 314: 311: 308: 287:navbox, sidebar 281: 276: 271: 270: 255:Clinical trials 230: 207: 170: 122: 99: 81: 54: 44: 12: 11: 5: 384: 382: 374: 373: 368: 366:Antipsoriatics 358: 357: 354: 353: 336:Antipsoriatics 329: 312:Antipsoriatics 273: 272: 269: 268: 267: 266: 263: 252: 246: 240: 239: 236: 235: 232: 231: 229: 228: 223: 217: 215: 209: 208: 206: 205: 200: 195: 189: 187: 180: 176: 175: 172: 171: 169: 168: 163: 157: 152: 147: 136: 130: 128: 124: 123: 121: 120: 115: 109: 107: 101: 100: 98: 97: 91: 89: 83: 82: 80: 79: 69: 67: 60: 56: 55: 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 383: 372: 369: 367: 364: 363: 361: 330: 306: 305: 304: 303:may be used: 302: 294: 292: 288: 284: 264: 262: 259: 258: 256: 253: 250: 247: 245: 242: 241: 237: 227: 224: 222: 219: 218: 216: 214: 210: 204: 201: 199: 196: 194: 191: 190: 188: 184: 181: 177: 167: 164: 161: 158: 156: 153: 151: 148: 146: 142: 141: 137: 135: 132: 131: 129: 125: 119: 116: 114: 111: 110: 108: 106: 102: 96: 93: 92: 90: 88: 84: 78: 74: 71: 70: 68: 64: 61: 57: 52: 48: 41: 36: 34: 29: 27: 22: 21: 18: 295: 282:autocollapse 279: 277: 145:Calcipotriol 138: 134:Fumaric acid 23: 251:from market 198:Methoxsalen 193:Trioxysalen 118:Methoxsalen 113:Trioxysalen 360:Categories 221:Etretinate 166:Tazarotene 160:Tacalcitol 155:Calcitriol 323:collapsed 301:parameter 261:Phase III 249:Withdrawn 226:Acitretin 213:Retinoids 203:Bergapten 186:Psoralens 140:vitamin D 105:Psoralens 95:Dithranol 87:Antracens 347:expanded 179:Systemic 77:Coal tar 59:Topical 244:WHO-EM 342:state 318:state 289:, or 127:Other 66:Tars 73:Tar 51:D05 362:: 349:}} 333:{{ 325:}} 309:{{ 257:: 75:/ 345:= 339:| 321:= 315:| 162:) 143:( 53:) 49:( 39:e 32:t 25:v

Index

v
t
e
Drugs used for psoriasis
D05
Tar
Coal tar
Antracens
Dithranol
Psoralens
Trioxysalen
Methoxsalen
Fumaric acid
vitamin D
Calcipotriol
Calcipotriol/betamethasone
Calcitriol
Tacalcitol
Tazarotene
Trioxysalen
Methoxsalen
Bergapten
Retinoids
Etretinate
Acitretin
WHO-EM
Withdrawn
Clinical trials
Phase III
navbox, sidebar

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.